Literature DB >> 15302848

Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.

Magdalena Wojtasiak1, Claerwen M Jones, Lucy C Sullivan, Adam C Winterhalter, Francis R Carbone, Andrew G Brooks.   

Abstract

Subsets of CD8 T cells express receptors that are critical in regulating the activity of NK cells. To characterize the expression of these receptors on CD8 T cells we made use of transgenic mice that express a H-2Kb restricted TCR specific for the immunodominant epitope located within the HSV-1 glycoprotein B (gB). Few naive gB-specific T cells express Ly49 or CD94/NKG2 receptors. Following acute infection of C57BL/6 mice with either HSV-1 or a recombinant influenza virus that encodes the gB determinant, gB-specific T cells showed a dramatic upregulation of CD94/NKG2 receptors. Moreover, gB-specific CD8 T cells that expressed CD94/NKG2 receptors were also found to express another NK receptor, KLRG1. We established that while Ag-stimulated gB-specific CD8 T cells primarily express inhibitory isoforms of CD94/NKG2 receptors, these cells remain capable of producing gammaIFN upon peptide stimulation. While peak CD94/NKG2 expression on gB-specific cells was reached 2-3 days following infection, it remained elevated beyond 60 days post-infection with either HSV-1 or a gB-expressing recombinant influenza virus. The data imply that the prolonged expression was not due to persistence of replicating virus and suggest that while recognition of the cognate Ag is necessary to trigger expression of CD94/NKG2 receptors, it is not required for their continued expression on memory T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302848     DOI: 10.1093/intimm/dxh136

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.

Authors:  Dana R Marshall; Elvia Olivas; Samita Andreansky; Nicole L La Gruta; Geoff A Neale; Astrid Gutierrez; David G Wichlan; Suzette Wingo; Cheng Cheng; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-14       Impact factor: 11.205

Review 3.  Control of HSV-1 latency in human trigeminal ganglia--current overview.

Authors:  Kathrin Held; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

Review 4.  A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.

Authors:  Sherrie Divito; Thomas L Cherpes; Robert L Hendricks
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Authors:  Christopher C Kemball; Eva Szomolanyi-Tsuda; Aron E Lukacher
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?

Authors:  Christine M Graham; Jillian R Christensen; D Brian Thomas
Journal:  Immunology       Date:  2007-06       Impact factor: 7.397

7.  Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea.

Authors:  Jared E Knickelbein; Sherrie Divito; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

Review 8.  Neurons under viral attack: victims or warriors?

Authors:  Swarupa Chakraborty; Arshed Nazmi; Kallol Dutta; Anirban Basu
Journal:  Neurochem Int       Date:  2010-03-04       Impact factor: 3.921

9.  Functional Characterization of Ly49+CD8 T-Cells in Both Normal Condition and During Anti-Viral Response.

Authors:  Dmytro Shytikov; Deepak Rohila; Dan Li; Pengfei Wang; Mei Jiang; Mingxu Zhang; Qin Xu; Linrong Lu
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.